vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Hyperscale Data, Inc. (GPUS). Click either name above to swap in a different company.
Hyperscale Data, Inc. is the larger business by last-quarter revenue ($26.9M vs $13.8M, roughly 2.0× FENNEC PHARMACEUTICALS INC.). FENNEC PHARMACEUTICALS INC. runs the higher net margin — -34.7% vs -112.0%, a 77.2% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 38.4%). Over the past eight quarters, Hyperscale Data, Inc.'s revenue compounded faster (-16.3% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Hyperscale Data, Inc. provides GPU-accelerated computing infrastructure and cloud solutions tailored for AI development, big data processing, and high-performance computing workloads. It primarily serves AI startups, large technology firms, and cloud service providers across North America and the Asia-Pacific region, delivering scalable, high-efficiency computing resources to support complex data processing needs.
FENC vs GPUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $26.9M |
| Net Profit | $-4.8M | $-30.1M |
| Gross Margin | — | 14.5% |
| Operating Margin | -18.5% | -117.8% |
| Net Margin | -34.7% | -112.0% |
| Revenue YoY | 73.8% | 38.4% |
| Net Profit YoY | -141.1% | -6670.3% |
| EPS (diluted) | $-0.17 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $26.9M | ||
| Q3 25 | $12.5M | $24.3M | ||
| Q2 25 | $9.7M | $25.9M | ||
| Q1 25 | $8.8M | $25.0M | ||
| Q4 24 | $7.9M | $19.4M | ||
| Q3 24 | $7.0M | $31.1M | ||
| Q2 24 | $7.3M | $17.8M | ||
| Q1 24 | $25.4M | $38.4M |
| Q4 25 | $-4.8M | $-30.1M | ||
| Q3 25 | $-638.0K | $-13.0M | ||
| Q2 25 | $-3.2M | $-19.1M | ||
| Q1 25 | $-1.2M | $-4.2M | ||
| Q4 24 | $-2.0M | $-445.0K | ||
| Q3 24 | $-5.7M | $-25.5M | ||
| Q2 24 | $-5.6M | $-33.9M | ||
| Q1 24 | $12.8M | $3.7M |
| Q4 25 | — | 14.5% | ||
| Q3 25 | — | 25.8% | ||
| Q2 25 | — | 23.7% | ||
| Q1 25 | — | 21.1% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 27.5% | ||
| Q2 24 | — | -21.3% | ||
| Q1 24 | — | 47.4% |
| Q4 25 | -18.5% | -117.8% | ||
| Q3 25 | -1.5% | -57.8% | ||
| Q2 25 | -28.3% | -39.2% | ||
| Q1 25 | -9.2% | -25.5% | ||
| Q4 24 | -11.8% | -46.8% | ||
| Q3 24 | -74.6% | -79.2% | ||
| Q2 24 | -69.4% | -151.4% | ||
| Q1 24 | 54.2% | 9.5% |
| Q4 25 | -34.7% | -112.0% | ||
| Q3 25 | -5.1% | -53.5% | ||
| Q2 25 | -32.7% | -73.7% | ||
| Q1 25 | -13.3% | -16.8% | ||
| Q4 24 | -25.0% | -2.3% | ||
| Q3 24 | -82.2% | -82.3% | ||
| Q2 24 | -76.5% | -190.7% | ||
| Q1 24 | 50.6% | 9.7% |
| Q4 25 | $-0.17 | — | ||
| Q3 25 | $-0.02 | $-0.39 | ||
| Q2 25 | $-0.11 | $-2.66 | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.02 | $-8.78 | ||
| Q3 24 | $-0.21 | $-24.82 | ||
| Q2 24 | $-0.20 | $-37.81 | ||
| Q1 24 | $0.41 | $3.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $13.1M |
| Total DebtLower is stronger | — | $83.1M |
| Stockholders' EquityBook value | $35.5M | $119.8M |
| Total Assets | $70.6M | $313.7M |
| Debt / EquityLower = less leverage | — | 0.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $13.1M | ||
| Q3 25 | $21.9M | $24.8M | ||
| Q2 25 | $18.7M | $5.9M | ||
| Q1 25 | $22.7M | $4.2M | ||
| Q4 24 | $26.6M | $4.5M | ||
| Q3 24 | $40.3M | $7.9M | ||
| Q2 24 | $43.1M | $9.6M | ||
| Q1 24 | $51.2M | $18.9M |
| Q4 25 | — | $83.1M | ||
| Q3 25 | $19.4M | $80.0M | ||
| Q2 25 | $19.4M | $88.5M | ||
| Q1 25 | $19.4M | $92.8M | ||
| Q4 24 | $19.3M | $96.7M | ||
| Q3 24 | $32.1M | $104.8M | ||
| Q2 24 | $31.8M | $106.8M | ||
| Q1 24 | $31.3M | $30.0M |
| Q4 25 | $35.5M | $119.8M | ||
| Q3 25 | $-4.5M | $55.9M | ||
| Q2 25 | $-7.5M | $5.5M | ||
| Q1 25 | $-5.9M | $6.3M | ||
| Q4 24 | $-5.9M | $8.6M | ||
| Q3 24 | $-5.2M | $2.7M | ||
| Q2 24 | $-1.4M | $26.7M | ||
| Q1 24 | $3.0M | $59.0M |
| Q4 25 | $70.6M | $313.7M | ||
| Q3 25 | $49.3M | $242.4M | ||
| Q2 25 | $44.9M | $213.5M | ||
| Q1 25 | $46.4M | $218.5M | ||
| Q4 24 | $44.9M | $220.8M | ||
| Q3 24 | $58.9M | $231.5M | ||
| Q2 24 | $63.2M | $270.8M | ||
| Q1 24 | $69.2M | $299.8M |
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 16.06× | ||
| Q1 25 | — | 14.71× | ||
| Q4 24 | — | 11.19× | ||
| Q3 24 | — | 38.41× | ||
| Q2 24 | — | 4.00× | ||
| Q1 24 | 10.40× | 0.51× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-37.7M |
| Free Cash FlowOCF − Capex | — | $-56.2M |
| FCF MarginFCF / Revenue | — | -208.7% |
| Capex IntensityCapex / Revenue | — | 68.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-87.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $-37.7M | ||
| Q3 25 | $1.5M | $-17.8M | ||
| Q2 25 | $-3.7M | $-3.1M | ||
| Q1 25 | $-4.3M | $-4.0M | ||
| Q4 24 | $-1.5M | $-9.2M | ||
| Q3 24 | $-2.2M | $3.7M | ||
| Q2 24 | $-8.4M | $-3.7M | ||
| Q1 24 | $39.0M | $-10.2M |
| Q4 25 | — | $-56.2M | ||
| Q3 25 | — | $-20.6M | ||
| Q2 25 | — | $-3.5M | ||
| Q1 25 | — | $-6.8M | ||
| Q4 24 | — | $-9.3M | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $-5.9M | ||
| Q1 24 | — | $-11.6M |
| Q4 25 | — | -208.7% | ||
| Q3 25 | — | -84.5% | ||
| Q2 25 | — | -13.5% | ||
| Q1 25 | — | -27.3% | ||
| Q4 24 | — | -47.6% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | — | -33.4% | ||
| Q1 24 | — | -30.3% |
| Q4 25 | — | 68.6% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 12.6% | ||
| Q1 24 | — | 3.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | -2.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
GPUS
| Transferred Over Time | $10.4M | 39% |
| Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities | $5.8M | 21% |
| Hotel And Real Estate Operations | $4.8M | 18% |
| Other | $4.0M | 15% |
| Turn On Green | $2.0M | 7% |
